Christopher Haqq's Insider Trades & SAST Disclosures

Christopher Haqq's most recent trade in Elicio Therapeutics Inc. was a trade of 44,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Elicio Therapeutics Inc.
Christopher Haqq See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 44,000 44,000 - - Stock Option (Right to Buy)
Elicio Therapeutics Inc.
Christopher Haqq See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 28,200 28,200 - - Stock Option (Right to Buy)
Elicio Therapeutics Inc.
Haqq Christopher See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 28,200 28,200 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades